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Abstract
Background:  Many case reports of acute pancreatitis have been reported but, up to now,
pancreatic abnormalities during acute gastroenteritis have not been studied prospectively.
Objectives:  To evaluate the incidence and the clinical significance of hyperamylasemia in 507
consecutive adult patients with acute gastroenteritis.
Methods:  The clinical significance of hyperamylasemia, related predisposing factors and severity
of gastroenteritis were assessed.
Results:  Hyperamylasemia was detected in 10.2 % of patients studied. Although amylasemia was
found over four times the normal values in three cases, the clinical features of acute pancreatitis
were recorded in only one case (0.1%). Hyperamylasemia was more likely (17%) where a
microorganism could be identified in the stools (p < 0.01). Among patients with positive stool
samples, Salmonella spp. and in particular S. enteritidis, was the microorganism most frequently
associated with hyperamylasemia [17/84 (20.2 %) and 10/45 (22.2%), respectively], followed by
Rotavirus, Clostridium difficile and Campylobacter spp. Patients with hyperamylasemia had more severe
gastroenteritis with an increased incidence of fever (80 % vs 50.6 %, O.R. 3.0; P < 0.01), dehydration
(18% vs 8.5%; O.R. 2.5; P < 0.05), and a higher mean number of evacuations per day (9.2 vs 7.5; P
< 0.05) than those with amylasemia in the normal range. Hyperamylasemia was significantly
associated with cholelithiasis, (30.0 % vs 10.7%, O.R. 3.5; P < 0.01) and chronic gastritis or duodenal
ulceration (22.0 % vs 10.2%, O.R. 2.4, P < 0.05).
Conclusions:   Hyperamylasemia is relatively frequent, and is associated with severe
gastroenteritis. However, acute pancreatitis in the setting of acute gastroenteritis, is a rare event.
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Introduction
A wide variety of infectious agents have been associated
with acute pancreatitis. Pathologic and radiological evi-
dence of pancreatitis in the course of well documented
infection has been associated with viruses, bacteria, fun-
gi and parasites [1]. In particular, a high incidence of
acute pancreatitis in adult patients with Salmonella in-
fection has been reported by Renner F. et al. [2]. In this
study, although pancreatic enlargement was demon-
strated by abdominal sonography in about half of pa-
tients, the course of pancreatitis was mild or moderate
with complete recovery. However, many case reports of
clinical severe acute pancreatitis during salmonellosis
have been reported, suggesting that serious pancreatic
disease may represent a complication of Salmonella in-
fection [3–10]. Similarly, acute pancreatitis has sporadi-
cally been reported during Campylobacter enteritis as
well as Rotavirus infection [11–14]. Up to now, pancreat-
ic abnormalities during acute gastroenteritis have not
been studied prospectively. To evaluate the incidence,
the clinical features and the relationship with predispos-
ing factors of hyperamylasemia we prospectively studied
a large number of patients consecutively hospitalised
with a diagnosis of acute gastroenteritis.
Patients and Methods
From January 1996 to December 2000, 507 consecutive
adult patients (males = 224, females = 283, mean age
41.6 (19.5, range 18–92) with acute gastroenteritis and
admitted to the Infectious Diseases Department of S.
Bortolo Hospital, Vicenza (North East Italy) were en-
rolled in this study. None of the cases studied had a pre-
vious history of pancreatic disease and none declared an
alcohol intake more than 40 grams per day.
At admission, severity of the disease was scored accord-
ing to the criteria reported by Goodman et al [15]. Briefly,
gastroenteritis was defined as grade 1 in patients with 4
or less evacuations per day, without any systemic signs
or symptoms; grade 2, with more than 4 evacuations per
day with or without systemic signs or symptoms and
grade 3, more than 6 evacuations per day associated with
one or more of the following signs and symptoms: fever
(>38°C), nausea, vomiting, malaise, dehydration, tenes-
mus, abdominal pain and blood and/or leukocytes in the
stools. Dehydration was evaluated at the time of hospi-
talisation (skin turgor and tongue hydration) and classi-
fied as present or absent. Age, gender, medical history,
current diseases and duration of hospitalisation were re-
corded.
Faecal specimens (collected after natural evacuation at
admission, after 24 and 36 hours) were cultured and an-
alysed by direct examination for the presence of blood,
leukocytes and parasites (May Grunwald Giemsa).
Cryptosporidium oocysts were sought by acid-fast Ziehl-
Neelsen method. All samples were also tested for Rotavi-
rus by using latex agglutination assays (Orion Diagnosti-
ca, Espoo, Finland). All patients underwent routine
blood and biochemistry tests (leucocytes and red cells
count, transaminases, Y-glutamil transpeptidase, alka-
line phosphatase, bilirubin, electrolytes, creatinine,
erythrosedimentation rate, cholesterol and try-
glicerides). Blood cultures were performed in patients
with temperature above 38°C. Amylasemia was tested at
admission, and at least twice during hospitalisation, by a
specific colorimetric test for the pancreatic subunit ac-
cording to the manufacturer's instruction (iso-amylase
pancreatic, ALIFAX S.p.A Padua, Italy). This method
uses a monoclonal antibody that specifically pre-inhibits
human salivary alpha-amylase (EC 3.2.1.1), and cross re-
acts negligibly with the pancreatic isoenzyme [16].
Amylasemia was recorded in 64 cases of non-infectious
diarrhea (mushroom poisoning, hospitalised from 1996
to 2000) and in 50 patients with various infectious dis-
eases (36 bacterial pneumonia, 5 patients urinary tract
infection and sepsis, 4 bacterial meningitis, 5 Staphylo-
coccus aureus infection) as negative control groups. All
patients with hyperamylasemia were examined by ultra-
sonography. Acute pacreatitis was defined accordingly to
the Atlanta classification [17].
Statistical Analysis
Student's t test was used to compare mean values. Chi-
square, Chi-square for linear trend and Fisher's exact
tests were used for comparing proportions. The Odds ra-
tio and Confidential Intervals (C.I.) at 95% were calculat-
ed by Fleiss quadratic method; for all results, upper and
lower C.I. limits for 95% are given. All P values are two-
tailed; a P values < 0.05 was considered statistical signif-
icance.
Results
At admission, hyperamylasemia (mean levels 195 UI/ L,
range 130–1560 UI, normal values <115 UI/L) was found
in 10.2% (50/507), 1.5% (1/64), and 0 % (0/50) of pa-
tients with acute gastroenteritis, non infectious diarrhea
(mushroom poisoning), and various infectious diseases,
respectively (P < 0.01). In three cases amylasememia
was found over four times the normal range (460 UI/L,
520 UI/L and 1560 UI/L, respectively) but only one case
(amylase 1560 UI/L) had the clinical features of acute
pancreatitis (typical pain with radiation, and poor re-
sponse to normal analgesics and antispastic drugs).
None of the patients with a normal amylasemia at admis-
sion developed hyperamylasemia during hospitalisation.
Patients with and without hyperamylasemia were com-
parable in terms of gender, mean age, frequency of anti-
biotic therapy, duration of evacuations before admissionBMC Infectious Diseases 2001, 1:18 http://www.biomedcentral.com/1471-2334/1/18
and frequency of abdominal pain (Table 1I). The charac-
teristics of abdominal pain (escluding the case with overt
pancreatitis) were similar in both groups. The pain,
strictly correlated with the course of gastroenteritis, was
mainly localised in the central abdomen, without radia-
tion and with a good responsiveness to antispatic drugs.
Moreover, cholesterol, thriglicerides alkaline phosfatase,
Y-glutamil-transpeptidase, transaminases, bilirubin se-
rum levels did not differ significantly between patients
with and without hyperamylasemia. Furthermore, hy-
peramylasemia was unrelated to impaired renal function
[mean creatinine serum levels was 0.8 ± 0.3 mgr/dl –
normal values < 1.2 mgr/dl – in patients with hyperamy-
lasemia and 0.9 ± 0.4 mgr/dl in patients with amylasem-
ia in the normal range]. Instead, an elevated erythrocyte
sedimentation rate was found associated with hyper-
amylasemia (mean values 31.3 versus 21.3; P < 0.05).
Univariate analyses demonstrated that hyperamylasem-
ia was significantly associated with cholelithiasis or pre-
vious cholecystectomy, as well as gastric or duodenal
diseases (chronic gastritis or duodenal ulcer) (Table 1I).
In the acute gastroenteritis group, hyperamylasemia was
recorded in 28 (17%) of the 164 cases with an identified
microorganism in stool samples and in 22 (6.4%) of the
343 cases without a microbiological diagnosis (P < 0.01).
Hyperamylasemia was significantly associated with the
severity of gastroenteritis, and the severity of gastroen-
teritis was significantly associated with the detectability
of microorganisms in stool samples [severity score,
grade 2 or 3 in 156 (98%) of patients with positive stool
samples versus 176 (51.4%) in patients with negative
stool samples, P < 0.01, Table 1I] . Among patients with
positive stool samples, Salmonella spp. and in particular
S. enteritidis, was the microorganism most frequently
associated with hyperamylasemia [17/84 (20.2 %) and
10/45 (22.2%), respectively], followed by Rotavirus,
Clostridium difficile and Campylobacter spp. (Fig. 1). In
5 patients Salmonella infection was accompained by sep-
sis (bacteremia in presence of systemic signs and symp-
toms of acute infection): all these cases had amylasemia
in the normal range. The patient with clinical features of
acute pancreatitis and the other two cases with amy-
lasemia over four times the normal range had cholelithi-
asis and Salmonella-related acute gastroenteritis.
Table I: Clinical features of patients with and without hyperamylasemia during acute gastroenteritis
Hyper amylasemia Normal amylasemia
Variables N = 50 (>115 U/L) N = 457 (≤  115 U/L) O.R.a C.I. 95% b
Sex (M/F) 21/29 203/254 0.9 0.4–7.9
Mean age (range) 41.8 ± 20.15 (10–80) 41.4 ± 19.1 (4–92) (-) (-)
Antibiotic therapy before 9 (18%) 63 (13.7%) 1.3 0.5 – 3.0
admission
Number 9.2 ± 5.8 7.5 ± 4.7 * (-) (-)
evacuations/day
Duration evacuations 3.17 ± 3.9 3.48 ± 5.3 (-) (-)
before admission (days)
Fever > 38°C 40 (80.0%) 258 (56.4%) ** 3.0 1.4–7.0
Vomiting 36 (72.0%) 287 (62.8%) 1.5 0.7–3.1
Abdominal pain 45 (90.0%) 395 (86.4%) 1.4 0.5–4.7
Severity score:
Grade 1 10 (6.0%) 160 (94%) ° 1.0
Grade 2 36 (11.5%) 278 (88.5%) ° 2.1
Grade 3 4 (17.3%) 19 (82.7%) ° 2.5
Dehydration 9 (18%) 39 (8.5%) * 2.0 0.8–4.8
Potential predisposing
factors
Cholelithiasis or 15 (30.0%) 49 (10.7%) ** 3.5 1.6–7.3
previous
cholecystectomy
Chronic gastritis and/or 11 (22.0%) 47 (10.2%) * 2.4 1.0–5.3
duodenal ulcer
* P < 0.05; ** P < 0.01;a, O.R. = Odds ratio; b C.I = Confidence interval 95%, ° Chi-square for linear trend 4.3, P < 0.05.BMC Infectious Diseases 2001, 1:18 http://www.biomedcentral.com/1471-2334/1/18
Clinical aspects
All patients recovered without any complications, in-
cluding the the case with acute pancreatitis. However, in
5 of 50 (10.0%), abnormal levels of amylasemia persisted
for more than 3 weeks. Ultrasound examination (per-
formed in all cases with hyperamylasemia) revealed pan-
creas enlargement in 2 cases (increased volume of the
head of the organ), not evaluable in 5 cases, and normal
in 43 cases. Dilatation of the bile ducts was observed in
none of the cases examined. In the patient with clinical
and laboratoristic features of acute pancreatitis, the di-
agnosis was confirmed with by CT scan performed with
contrast enhancement which allowed to identify an
oedematous form.
Discussion
In this study we prospectively evaluated the incidence of
hyperamylasemia, its clinical significance, and related
predisposing factors among 507 consecutive patients
with acute gastroenteritis. Although hyperamylasemia
was recorded in 10.2% of patients with gastroenteritis,
acute pancreatitis was observed in only one case (0.1%).
Hyperamylasemia correlated directly with the severity of
the disease, and its incidence was significantly higher in
patients with than patients without a microbiological di-
agnosis, and was particularly associated with Salmonella
infection (22%).
Although this association is lower than that reported by
Renner F. et al. [2], and by Hermans P. et al. [7], our data
Figure 1
Percentage of patients with hyperamylasemia according to microbiological diagnosis Among other microrganisms not reported
in the percentage, hyperamylasemia was recorded in 2 cases: 1 case positive for Strongiloides stercoralis and 1 positive for Giardia
lamblia.
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confirm, in a prospective study, that a real association
between Salmonella spp. and hyperamylasemia exists.
This could be explained in several different ways: Firstly,
intestinal inflammation could lead to an increased per-
meability which allows the reabsorption of macromole-
cules, such as amylase. This hypothesis has been
suggested by Gnadinger M.P. et al. [18], who demon-
strated an increased intestinal permeability for oral
51Cr-EDTA in two patients with elevated amylase serum
levels in the course of entero-invasive salmonellosis. Our
clinical findings, as well as those reported by other au-
thors, do not seem to confirm this hyphothesis, since
pancreatic enlargement and overt acute pancreatitis has
been demonstrated in the setting of acute gastroenteritis
[2,7].
Secondly, hyperamylasemia could be either the result of
a reduced excretion due to impaired renal function or the
result of a profound metabolic perturbation, as it has
been recently found in diabetic patients with ketoacido-
sis, whose amylasemia was significantly correlated with
PH. [19]. Since we have found no difference in term of
creatinine serum levels between patients with and with-
out hyperamylasemia, we can exclude the hypothesis of a
reduced excretion. Furthermore, considering that vomit-
ing is one of the main symptoms of gastroenteritis, the
PH trend tends to increase instead of decreasing.
Thirdly, hyperamylasemia could represent the effect of
the direct pancreatic localisation of bacteria. Theoreti-
cally, this could happen by a haematogenous route, lym-
phatic route, transmural migration, via the biliary duct
system and from the duodenum via the main pancreatic
duct. Involvement of the pancreas by bacteria through a
haematogenous route during acute gastroenteritis has
been suggested by Schimd et al. [20]. This hypothesis is
in contrast with our findings, since in five patients where
Salmonella spp. could be isolated from blood cultures,
hyperamylasemia was not detected. However, bacteria
may directly infect the pancreas via the biliary duct sys-
tem or the duodenum. This mechanism is supported by
well documented experimental data [21].
In animal models, perfusion of bile-pancreatic duct with
human infected bile induced irreversible duct damage
and complete loss of duct integrity, and resulted in acute
pancreatitis even at low perfusion pressures. The severi-
ty of acute pancreatitis depended on the bacterial species
[22,23]. Furthermore, cholelithiasis represents "per se"
one of the main risk factor of acute pancreatitis. Our da-
ta, demonstrating a significant association between hy-
peramylasemia and cholelithiasis, are in agreement with
both theories. We can speculate that bacteria may facili-
tate the precipitation of biliary sludge (microlithiasis) in-
ducing either an elevated ductal pressure leading to
intracellular enzyme activation or facilitating direct inju-
ry of the pancreas by bacteria [27].
Alternatively, hyperamylasemia could simply represent
an epiphenomena of a "biliary colic" in patients with gall-
bladder and dehydration secondary to water loss in-
duced by acute gastroenteritis.
The association between chronic gastritis and or duode-
nal ulcer and hyperamylasemia could be explained by an
increase risk of severe gastroenteritis in the presence of
an increased intraluminal PH, related to the therapy with
anti-secretory drugs. Treatment with anti-secretory
drugs, by reducing the gastric killing of ingested organ-
isms, has been shown to represent a risk factor for sal-
monella infection and its severity [24].
Despite the relative high rate of hypermaylasemia during
acute gastroenteritis, pancreatitis is a rare event. It is
reasonable to think that acute pancreatitis is the result of
an imbalance among predisposing factors, direct injury,
and protective mechanisms. Probably, in the setting of
acute gastroenteritis, the onset of overt pancreatitis is in-
fluenced by host factors (genetic predisposition, and/or
inflammatory response) as well as other possible still un-
identified factors. Further studied are need to clarify this
point.
Conclusion
Our study demonstrates that hyperamylasemia during
gastroenteritis is quite frequent, and mainly associated
with severe Salmonella infection, but overt panreatitis is
a rare event.
Competing interests
None declared.
References
1. Parenti DM, Steinberg W, Kang P: Infectious causes of acute pan-
creatitis. Pancreas 1996, 13:356-71
2. Renner F, Nimeth C, Demmelabauer R: High frequency of con-
comitant pancreatitis in Salmonella enteritidis. Lancet 1991,
337:1611
3. Andren-Sandberg A, Hojer H: Necrotizing acute pancreatitis in-
duced by Salmonella infection. Int J Pancreatol 1994, 15:229-30
4. Hamaguchi H, Okabayashi Y, Yoneda R, Ueeno H, Yoon S, Sakaue
KM: A case of acute pancreatitis complicating Salmonella en-
teritis. Int J Pancreatol 1999, 26:198-92
5. Pastore M, Pellegrino M, Maruzzi M, Meledeo D, D'Altilia MR, Sacco
M:  Pancreatitis associated with Salmonella.  Minerva Pediatr
1993, 45:471-73
6. Poza JJ, Amato E, Mentxaka B: Pancreatic changes associated
with acute gastroenteritis. Rev Clin Exp 1992, 101:308-10
7. Hermans P, Gerard M, van Laethem Y, de Wit S, Clumeck N: Pan-
creatic disturbances and typhoid fever. Scand J Infect Dis 1991,
23:201-5
8. Abdulla AJ, Moorhead JF, Sweny : Acute tubular necrosis due to
rhabdomyolysis and pancreatitis associated with Salmonella
enteritidis food poisoning. Nephrol Dial Transplant 1993, 8:672-3
9. Murphy S, Beeching NJ, Rogerson SJ, Harries AD: Pancreatitis as-
sociated with Salmonella enteritis. Lancet 1991, 338:571BMC Infectious Diseases 2001, 1:18 http://www.biomedcentral.com/1471-2334/1/18
10. Ginsburg C, Raffenne L: Typhoid fevers complicated by acute
renal failure, by rhabdomyolysis and by acute pancreatitis.
Rev Med Interne 1989, 10:279-80
11. Coton T, Carre D, Rey P, Faure P, Guisset M, Debonne JM: Acute
pancreatitis and Campylobacter enteritis. Gastroenterol Clin Biol
2000, 24:238-239
12. Peterson MC: Clinical aspects of Campylobacter jejuni infec-
tions in adults. West J Med 1994, 161:148-52
13. De La Rubia L, Herrera MI, Cebrero M, De Jong JC: Acute pancre-
atitis associated with Rotavirus infection . Pancreas 1996, 12:98-
99
14. Nigro G: Pancreatitis with hypoclycemia – associated convul-
sion following rotavirus gastroenteritis. J Pediatr Gastroenterol
Nutr 1991, 12:280-282
15. Goodman J, Trenholme G: Infectious diarrhea. Current practice of
medicine 1999, 4:583-589
16. Gerber M, Naujooks H, Lenz H, Wullf K: A monoclonal that spe-
cifically inhibits human salivary alpha-amylase. Clin Chem 1987,
33:1158-62
17. Bradley EL: A clinically based classification of acute pancreati-
tis. Summary of the international symposium on acute pan-
creatitis. Atalanta, GA, September 11 through 13, 1992. Arch
Surg 1993, 128:586-590
18. Gnadinger MP, Eigenmann F, Bekier A, Galeazzi RL: Pseudopancre-
atitis in entero-invasive salmonellosis. Schweiz Med Wochenschr
1993, 123:1482-86
19. Yadav D, Nair S, Norkus EP, et al: Nonspecific hyperamylasemia
and hyperamylasemiain diabetic ketoacidosis; incidence and
correlation with biochemical abnormalities. Am J Gastroenterol
2000, 95:3123-28
20. Schmid SW, Malfertheiner P, Bucher MW: The role of infection in
acute pancreatitis. Gut 1999, 45:311-6
21. Arendt T: Bile-induced acute pancreatitis in cats. Roles of bile,
bacteria, and pancreatic duct pressure. Dig Dis Sci 1993, 38:39-
44
22. Armstrong CP, Taylor TV, Torrance HB: Effects of bile, infection
and pressure on pancreatic duct integrity.  Br J Surg 1985,
72:792-795
23. Arendt T, Nizze H, Stuber E, Monig H, Kloehn S, Folsch UR: Infected
bile-induced acute pancreatitis in rabbits. The role of bacte-
ria. Int J Pancreatol 1998, 24:111-16
24. Neal K, Briji SO, Slack RC, Hawkey CJ, Logan RF: Recent treat-
ment with H2 antagonists and antibiotics and gastric surgery
as risk factors for Salmonella infection. BMJ 1994, 308:176
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com